top of page
News & Insights
Updates and insights from DHT.health
Modelling Techniques in Economic Evaluation of Bleeding Disorders: A Comparative Overview
Inherited bleeding disorders (iBDs), such as haemophilia A and B, von Willebrand disease (VWD), and Glanzmann thrombasthenia, present unique challenges for health technology assessment (HTA). Treatments are often lifelong, costly, and evolving rapidly, especially with the advent of gene therapies and non-factor replacement options like emicizumab. Economic evaluations (EEs) are essential to guide reimbursement and policy decisions, and modelling plays a central role in these
DHT.health
5 days ago3 min read
Empowering Patient Voices in HEOR: The Critical Role of Patient-Generated Data and Preferences in Europe’s Evolving HTA Landscape
Patient-Generated Data and Preferences in Europe's evolving HTA landscape.
DHT.health
Nov 6, 20242 min read
Integrating Primary and Secondary HEOR Research to Enhance Outcomes
Integrating primary and secondary HEOR research to enhance outcomes.
DHT.health
Jun 27, 20242 min read
Health Economics and Outcomes Research (HEOR) in Rare Diseases: A Crucial Tool for Advancing Patient Care
This article explains the importance and challenges of conducting Health Economics and Outcomes Research in Rare Diseases.
DHT.health
May 29, 20242 min read
bottom of page